These results are also in agreement with previous reports of apoptosis being regulated by E2F1/E2F3/Caspase-3 axis in HCC cells, which guarantees further studies for molecular mechanisms of Tiliroside on HCC treatment. The gene discussed is E2F3; the disease is hepatocellular carcinoma.